Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer

Aditya Bardia1, Barbara Pistilli1, Hope Rugo1

  • 1Aditya Bardia, MD, MPH, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, Massachusetts General Hospital Cancer Center, Boston, MA; Barbara Pistilli, MD, Gustave Roussy Cancer Center, Villejuif, France; and Hope Rugo, MD, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.

Abstract

No abstract available in PubMed .